Suppr超能文献

下一代测序检测北印度FXIII缺乏症患者中F13A1的基因谱

Genetic Spectrum in F13A1 Detected by Next-Generation Sequencing Among North Indian Patients with FXIII Deficiency.

作者信息

Sharma Ritika, Jamwal Manu, Singh Namrata, Sharma Prashant, Bansal Deepak, Trehan Amita, Malhotra Pankaj, Jain Arihant, Ahluwalia Jasmina, Das Reena, Kumar Narender

机构信息

Department of Hematology, Postgraduate Institute of Medical Education and Research, 160012 Chandigarh, India.

Department of Pediatrics (Hematology-Oncology Unit), Postgraduate Institute of Medical Education and Research, 160012 Chandigarh, India.

出版信息

Indian J Hematol Blood Transfus. 2023 Apr;39(2):276-283. doi: 10.1007/s12288-022-01579-1. Epub 2022 Nov 1.

Abstract

PURPOSE

The study aimed to explore the molecular defects underlying FXIII deficiency.

MATERIALS AND METHODS

Sixteen unrelated cases were enrolled based on the indication of the urea clot solubility test and Factor XIII-A antigen levels. Cases were further subjected to targeted next-generation sequencing (custom gene panel: , , , , The pathogenic/likely pathogenic variants were validated by Sanger sequencing in the patients and family members.

RESULTS

Mean age of referral to our center was 27.2 years (8 week-67 years). Consanguinity was found in only one of the 16 cases and 9 cases presented in infancy. The most common symptoms were skin bleeds (69%) and umbilical cord bleed (50%). The clot solubility test was positive in 12, inconclusive in 1, and normal in 3. Mean FXIII-A levels were 15.7 IU/dL (range 0.6 to 49.5 IU/dL). Pathogenic/likely pathogenic variants in were found in 11 (69%). Nine cases (82%) were homozygous, and two were compound heterozygous. Total eleven variants were found of which four were missense (c.1226G>A; c.998C>T; c.631G>C; c.2134A>C); three deletion (c.521delG; c.742delA; c.1405_1408delCAAA); two nonsense (c.1112G>A; c.1127G>A) and two splice site (c.1909-1G>C; c.2045G>A). No probably pathogenic variant was found in the .

CONCLUSION

Inherited FXIII deficiency with bleeding is associated with genetic defects in predominantly the gene. A variety of variants were seen in this cohort. A nonsense variant c.1127G>A found in three of our cases seems to be recurrent. This data will contribute to designing functional studies and antenatal testing in affected families.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s12288-022-01579-1.

摘要

目的

本研究旨在探究凝血因子 XIII 缺乏症潜在的分子缺陷。

材料与方法

根据尿素凝块溶解度试验结果及凝血因子 XIII - A 抗原水平,纳入 16 例无亲缘关系的病例。对病例进一步进行靶向二代测序(定制基因 panel:……)。通过 Sanger 测序在患者及其家庭成员中验证致病/可能致病的变异。

结果

转诊至我们中心的患者平均年龄为 27.2 岁(8 周 - 67 岁)。16 例中仅 1 例有近亲结婚情况,9 例在婴儿期发病。最常见的症状为皮肤出血(69%)和脐带出血(50%)。凝块溶解度试验 12 例呈阳性,1 例结果不确定,3 例正常。凝血因子 XIII - A 平均水平为 15.7 IU/dL(范围 0.6 至 49.5 IU/dL)。11 例(69%)发现 基因存在致病/可能致病的变异。9 例(82%)为纯合子,2 例为复合杂合子。共发现 11 种变异,其中 4 种为错义变异(c.1226G>A;c.998C>T;c.631G>C;c.2134A>C);3 种为缺失变异(c.521delG;c.742delA;c.1405_1408delCAAA);2 种为无义变异(c.1112G>A;c.1127G>A);2 种为剪接位点变异(c.1909 - 1G>C;c.2045G>A)。 基因未发现可能致病的变异。

结论

遗传性凝血因子 XIII 缺乏伴出血主要与 基因的遗传缺陷有关。该队列中观察到多种变异。我们的 3 例病例中发现的无义变异 c.1127G>A 似乎具有复发性。这些数据将有助于为受影响家庭设计功能研究和产前检测。

补充信息

在线版本包含可在 10.1007/s12288 - 022 - 01579 - 上获取的补充材料。 1

相似文献

1
Genetic Spectrum in F13A1 Detected by Next-Generation Sequencing Among North Indian Patients with FXIII Deficiency.
Indian J Hematol Blood Transfus. 2023 Apr;39(2):276-283. doi: 10.1007/s12288-022-01579-1. Epub 2022 Nov 1.
2
Identification of a novel mutation in the factor XIII A subunit in a patient with inherited factor XIII deficiency.
Int J Hematol. 2023 Jul;118(1):26-35. doi: 10.1007/s12185-023-03594-y. Epub 2023 Apr 14.
6
Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A.
Haemophilia. 2017 May;23(3):e194-e203. doi: 10.1111/hae.13233.
7
A common F13A1 intron 1 variant IVS1+12(A) is associated with mild FXIII deficiency in Caucasian population.
Ann Hematol. 2013 Jul;92(7):975-9. doi: 10.1007/s00277-013-1724-2. Epub 2013 Mar 19.
9
Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency.
Blood Coagul Fibrinolysis. 2015 Jan;26(1):46-9. doi: 10.1097/MBC.0000000000000171.
10
Molecular spectrum of inherited FVII deficiency in North India revealed a recurrent variant with a founder effect.
Haemophilia. 2023 Mar;29(2):591-599. doi: 10.1111/hae.14730. Epub 2022 Dec 26.

本文引用的文献

1
Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.
Int J Mol Sci. 2021 Mar 17;22(6):3055. doi: 10.3390/ijms22063055.
2
Factor XIII mutation spectrum in Iranian patients with hereditary factor XIII deficiency: Detection of 3 novel mutations.
Int J Lab Hematol. 2019 Jun;41(3):e61-e65. doi: 10.1111/ijlh.12959. Epub 2018 Dec 22.
3
Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A.
Haemophilia. 2017 May;23(3):e194-e203. doi: 10.1111/hae.13233.
4
Molecular Basis of Congenital Factor XIII Deficiency in Iran.
Clin Appl Thromb Hemost. 2018 Mar;24(2):210-216. doi: 10.1177/1076029616680473. Epub 2016 Nov 23.
5
First trimester prenatal diagnosis of severe FXIII deficiency.
Haemophilia. 2016 Sep;22(5):e443-4. doi: 10.1111/hae.12982. Epub 2016 Jun 24.
6
Diagnosis and Management of Congenital and Acquired FXIII Deficiencies.
Semin Thromb Hemost. 2016 Jun;42(4):429-39. doi: 10.1055/s-0036-1572326. Epub 2016 Apr 12.
7
Genetic basis of severe factor XIII deficiency in a large cohort of Indian patients: Identification of fourteen novel mutations.
Blood Cells Mol Dis. 2016 Mar;57:81-4. doi: 10.1016/j.bcmd.2016.01.002. Epub 2016 Jan 13.
9
Diagnosis and classification of factor XIII deficiencies.
J Thromb Haemost. 2011 Jul;9(7):1404-6. doi: 10.1111/j.1538-7836.2011.04315.x.
10
Mutations in coagulation factor XIII subunit A in severe factor XIII deficiency patients: five novel mutations detected.
Haemophilia. 2011 Sep;17(5):e843-5. doi: 10.1111/j.1365-2516.2011.02590.x. Epub 2011 Jun 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验